Evidence-Based Practices to Optimize Prescriber Use of PDMPs
|
|
- Sophia Short
- 6 years ago
- Views:
Transcription
1 Evidence-Based Practices to Optimize Prescriber Use of PDMPs Sheri Lawal, MPH, CHES Senior Associate, Substance Use Prevention and Treatment Initiative, The Pew Charitable Trusts Thomas Clark Research Associate, Institute for Behavioral Health at the Heller School for Social Policy and Management, Brandeis University Jean Hall ekasper Integration Project Manager, Kentucky Cabinet for Health and Family Services
2 Overview Background Methodology Overview of report findings Select practices Perspective from Kentucky Q&A
3 Background PDMPs valuable patient care and public health tools Opportunity to increase prescriber use of PDMPs Median enrollment rate, 2014: 31.7% 1 22% of primary care physicians did not know whether their state had a PDMP 2 Only 53% reported ever using the PDMP 2 1 Survey conducted by Brandeis University PDMP Center of Excellence and The Pew Charitable Trusts from November to December Rutkow et al., Health Affairs 34, no. 3 (2015): ,.
4 Report Overview Released December 2016 Examined 8 evidencebased practices to increase prescriber use of PDMPs Case studies of states that have implemented practices Additional and emerging practices
5 PDMP Practices Evaluated Prescriber use mandates Delegation Unsolicited reports Data timeliness Streamlined enrollment Educational and promotional initiatives Health information technology integration Enhanced user interfaces
6 Methods Literature review Search of PDMP-related websites Selection of state case studies on implementing PDMP practices Survey of states on practices, enrollment, and utilization External peer review of paper by PDMP staff and other stakeholders
7 Survey Goal: get snapshot of states on practice implementation and prescriber utilization Received data on practice implementation from 48 of 50 operational PDMPs Received data on prescriber/delegate enrollment and utilization from 42 of 50 operational PDMPs Variation among states in practice adoption, prescriber enrollment and utilization Variability among PDMPs in capacity to report enrollment and utilization measures
8 Limitations Few published studies on practices to increase PDMP utilization Multiple concurrent practices and interventions make assessment of impact difficult Surveys, process and outcome data suggest efficacy of practices Variation in evidence: prescriber mandates have clearest measurable impact Moving target: states continually enhancing their PDMPs with novel and updated practices
9 Report Findings Prescriber use mandates rapidly increase PDMP utilization and can have an immediate impact on prescriber behavior Delegate accounts, daily dispenser reporting, and streamlined enrollment are practical solutions that are feasible to implement Unsolicited reporting and educational and promotional initiatives encourage use of PDMPs Health IT integration and enhanced user interfaces address barriers to using PDMPs
10 Mandates
11
12 Mandates: Evidence of Effectiveness Reductions in the number of opioid prescriptions NY: 8.7% decrease in the year following the mandate Increases in registration and utilization of the PDMP NY: increase from 11,000 to 1.2 million queries Reductions in multiple provider episodes NY: 91.2% decrease between the 4 th quarter of 2012 and the fourth quarter of 2015
13
14 Mandates: Implementation Challenges and Solutions Challenge: Additional workload Solutions: Allow ample time to implement the mandate Increase PDMP staffing Shift to paperless online registration Challenge: Increased demand on IT systems Solution: Upgrade the software and system hardware
15 Mandates: Implementation Challenges and Solutions Challenge: Concern from prescriber communities Solutions: Allow for exceptions for required checking of the PDMP Allow delegates to obtain reports Engage prescriber organizations to develop provisions Prescriber education
16 Delegation
17
18 Delegation: Evidence of Effectiveness Increases PDMP use OR: delegates accounted for ¼ of PDMP queries and overall PDMP use increased by 30% KY: delegates accounted for 42% of accounts, but requested ~64% of reports Reductions in multiple provider episodes Reductions in controlled substance prescriptions
19
20 Delegation: Implementation Challenges and Solutions Challenge: Administrative burden to register delegates Solutions: Allow delegates the ability to register online Hold prescribers responsible for verifying their delegates Challenge: Protecting patient privacy and confidentiality Solution: Limit delegate accounts to licensed staff
21 Delegation: Implementation Challenges and Solutions Challenge: Reducing prescriber s burden Solutions Allow prescribers ability to view and download a report of delegates activity Allow prescribers ability to audit multiple delegates with a single query
22 Health information technology (HIT) integration
23
24 HIT Integration: Evidence of Effectiveness Users report data are easier to access Indiana ONC pilot #1: 97% of participating prescribers (N=243) reported that automatic queries to database made PDMP data easier to access Increased workflow satisfaction from having each patient s prescription information as part of the medical record Increases PDMP utilization Indiana ONC pilot #2: with PDMP access via HIE, total queries to the Indiana PDMP increased 59 percent over the prior month Washington state s ED Information Exchange (EDIE): automated queries made up nearly 60% of total queries to PDMP in 2015
25 HIT Integration: Implementation Challenges and Solutions Challenge: Need for resources to develop and test data systems Solutions: Federal grant programs (ONC, SAMHSA, CDC, BJA) Meaningful Use incentive program for EHRs State funding to providers, pharmacies and vendors Challenge: Secure data access and monitoring Solutions: Develop policies for EHR data storage Maintain audit trails for individual end-users User authentication from different access points
26 HIT Integration: Implementation Challenges and Solutions Challenge: Interoperability of disparate systems Solutions: Use small pilots to develop interface protocols, then scale up Compare direct-to-ehr vs. HIE-mediated approaches Learn from early adopters what does and doesn t work Challenge: Present clinically useful data Solutions: Pop-up prescription history reports in EHR, e.g., PDFs Only show report if patient meets risk threshold (EDIE) Display data using analytical tools (e.g., NARxCHECK)
27 Enhanced user interfaces
28
29 Enhanced Interfaces: Case Studies California: CURES 2.0 includes a high-risk alert dashboard Lists patients meeting risk thresholds when logged in: Over 100 MME/day >6 prescribers or >6 pharmacies in last 12 months Over 40 mg methadone daily Over 90 days of continuous opioid Rx Concurrent opioid and benzo Rx Generates patient safety alerts, enables peer communication Evaluation: will assess prescriber use of the dashboard, recommend modifications to assure maximum effectiveness
30 Enhanced Interfaces: Case Studies New Jersey: Developed first PDMP mobile phone app to view patient data Incorporates standard mobile security and functionality View same data elements as computer access Works independently of PDMP web portal Receives push alerts from PDMP, e.g., re fraudulent Rx Start up: $95,000 in development costs Regulatory and data sharing hurdles overcome 545 users had downloaded app as of November 2015; promotion underway as of 2016
31 Enhanced Interfaces: Case Studies Indiana: Implemented NARxCHECK analytical tool ONC Enhancing Access two-phase pilot: ED, then hospitals Tool includes Composite patient risk score MME data Graph of Rx history showing overlapping prescriptions Full patient report available 4,259 PDMP/NARxCHECK reports generated in one month 6% of reports suggested at risk patients: score >500 75% of at risk patients did not receive an opioid prescription 25% did receive opioids
32
33 Evidence-Based Practices to Optimize Prescriber Use of PDMPs A Kentucky Perspective Jean Hall, KASPER Integration Project Manager Kentucky Cabinet for Health & Family Services January 25, 2017
34 Kentucky Perspective Overview Recommended Practices State Kentuck y PDMP start date Unsolicit ed reports Delegati on Streamlin ed enrollme nt Prescrib er use mandat e Educatio nal and Promotio nal activities Mandat ed training Health IT integrati on Enhance d user interfac es Dispens er reportin g interval 1999 X p X p p p X p Daily Statute does not permit Initially for HB1 p
35 Prescriber Use Mandates House Bill 1 - passed on April 24, 2012 and was effective July 20, ekasper Accounts KRS 218A.202 ekasper registration is mandatory for Kentucky practitioners or pharmacists authorized to prescribe or dispense controlled substances to humans. ekasper Prescriber Usage KRS 218A.172 Query ekasper for previous 12 months of data: Prior to initial prescribing or dispensing of a Schedule II controlled substance, or a Schedule III controlled substance containing hydrocodone No less than every three months Review data before issuing a new prescription or refills for a Schedule II controlled substance or a Schedule III controlled substance containing hydrocodone Additional rules/exceptions included in licensure board regulations
36 Prescriber Use Mandates What if I cannot query ekasper? If ekasper indicates manual process (Manual processed reports are reviewed by a staff member before release) Record the ekasper report request number in the patient s chart If the ekasper system is unavailable or Internet access unavailable Document circumstances why ekasper could not be queried If ekasper outage, record the date and time, and ekasper system outage logs will confirm lack of system availability
37 Prescriber Use Mandates ekasper Query Exceptions In an emergency situation Within 14 days of surgery or within three days of oral surgery Patients in hospitals and long term care facilities Patients in Hospice care or being treated for cancer pain Single doses of anxiety medicine prior to a procedure
38 Results of Prescriber Use Mandates HB1 July 20, Number of Controlled Substance Prescriptions per Person
39 Results of Prescriber Use Mandates Controlled Substance Dispensing Comparison Number of prescriptions dispensed as reported to KASPER
40 Multiple Provider Episodes
41 Delegation Delegates KRS 218A.202e Allows an employee of the practitioner's or pharmacist's practice acting under the specific direction of the practitioner or pharmacist, who requests information and certifies that the requested information is for the purpose of: 1. Providing medical or pharmaceutical treatment to a bona fide current or prospective patient;
42 Delegation Institutional Accounts for Hospitals and Long Term Care Facilities KRS 218A.202f Allows a chief medical officer, an employee designee who is working under the specific direction of chief medical officer or a physician designee if the Facility has no chief medical officer to designate delegates. Requires execution of an agreement: Institutional Account Agreement Institutional Account Agreement for Integration
43 Number of Reports in Thousands Results of Prescriber Use Mandates & Delegation HB1 July 20, ,871 7,354 4,587 4,992 2,
44 Data Timeliness Must be reported no later than the close of business on the business day immediately following the dispensing In house data collection effective March 2017
45 Educational and Promotional Initiatives Require 7.5% of CME in addiction, pain management or KASPER Grants allowed us to make CMEs available at no cost through University of Kentucky CE Central Publish promotional literature (brochures, fact sheets, signs, etc.) Provider Dispenser Law Enforcement Public Regularly provide educational and promotional presentations
46 Educational and Promotional Initiatives
47 Educational and Promotional Initiatives
48 Educational and Promotional Initiatives
49 Health Information Technology Integration Current The Kroger Company In Progress Kentucky Health Information Exchange Other potential initiatives DrFirst SpeedScript
50 Enhanced User Interface In-house development and support of ekasper KASPER Advisory Council feedback Provides guidance on potential ekasper enhancements Provides guidance on identifying potential inappropriate or illegal controlled substances prescribing Additional reports available to prescribes CS prescribers can obtain an ekasper report on themselves: To review and assess the individual prescribing patterns To determine the accuracy and completeness of information contained in ekasper To identify fraudulent prescriptions Summary report To review individual and delegate request history Peer Review Report Enhanced report features (e.g. Morphine Milligram Equivalents)
51 Active Cumulative Morphine Equivalent
52 Active Cumulative Morphine Equivalent
53 Other Keys to Success Strong leadership support, strong leadership Strong partnership between the business owners, Office of Inspector General and the technical team, Office of Administrative and Technical Services Successful partnerships at many levels Kentucky Office of Drug Control Policy Licensure Boards Professional Associations Stakeholder engagement
54 Jean Hall KASPER Integration Project Manager Cabinet for Health and Family Services #12 Mill Creek Park Frankfort KY x2499 KASPER Web Site:
55 Thank You Sheri Lawal, The Pew Charitable Trusts, Tom Clark, Institute for Behavioral Health, Heller School, Brandeis University, Jean Hall, Kentucky Cabinet for Health and Family Services,
56 Telephone: (781) Website:
Kentucky. Kentucky Cabinet for Health and Family Services Office of Inspector General
PDMP name: Agency responsible: Agency type: PDMP email: PDMP website: Enrollment website: Query website: Data upload website: Statistics website: Kentucky Kentucky Cabinet for Health and Family Services
More informationPrescription Drug Monitoring Program (PDMP)
Prescription Drug Monitoring Program (PDMP) New York State Information contained in this presentation is accurate as of September 2017 Meet the Speaker Anita Murray, R.Ph., Deputy Director Bureau of Narcotic
More informationTennessee. Contact Information. State Registrant Totals and Population. PDMP name: CSMD
Statistics website: Bess, D. Todd - Director, CSMD Program 665 Mainstream Drive Nashville TN 37243 Office: (615) 253-1305 Fax: Email: david.bess@tn.gov Tennessee PDMP name: CSMD PDMP region: South Agency
More informationNorth Carolina. Contact Information. State Registrant Totals and Population. PDMP region: PDMP name: Agency responsible:
PDMP name: Agency responsible: Agency type: PDMP email: PDMP website: Enrollment website: Query website: Data upload website: Statistics website: North Carolina PDMP region: South North Carolina Department
More informationAlaska. Contact Information. State Registrant Totals and Population. PDMP name: AKPDMP
Statistics website: Carrillo, Laura - PDMP Manager 550 W. 7th Ave, Ste 1500 Anchorage AK 99501 Office: (907) 269-8404 Fax: (907) 465-2974 Email: laura.carrillo@alaska.gov Alaska PDMP name: AKPDMP PDMP
More informationPrescription Drug Monitoring Program (PDMP)
Prescription Drug Monitoring Program (PDMP) West Virginia Information contained in this presentation is accurate as of October 2017 What is a Prescription Drug Monitoring Program? A PDMP/PMP is a statewide
More informationOhio. Contact Information. State Registrant Totals and Population
PDMP name: OARRS Agency responsible: State of Ohio Board of Pharmacy Agency type: Pharmacy Board PDMP email: info@pharmacy.ohio.gov PDMP website: www.ohiopmp.gov Enrollment website: https://ohio.pmpaware.net
More informationBJA COAP Category 5 Grantee Webinar Thursday, June 21, 2018
BJA COAP Category 5 Grantee Webinar Thursday, June 21, 2018 BJA Update Tara Kunkel Senior Drug Policy Advisor IPA Bureau of Justice Assistance U.S. Department of Justice BJA Grant Project Update: Washington
More informationSummer Webinar Series. The Prescription Drug Monitoring Program (PDMP) Mandate and Where you Fit In June 21, 2018
1 Summer Webinar Series The Prescription Drug Monitoring Program (PDMP) Mandate and Where you Fit In June 21, 2018 2 Introductions Lindsey Ferris, MPH Program Director, HIE Projects PDMP Subject Matter
More informationMichigan. Contact Information. State Registrant Totals and Population. PDMP name: MAPS
Michigan PDMP name: MAPS PDMP region: Agency responsible: Bureau of Professional Licensing, Drug Monitoring Section Agency type: Professional Licensing Agency PDMP email: BPL-MAPS@michigan.gov PDMP website:
More informationNew Mexico. Contact Information. State Registrant Totals and Population. PDMP name: NM PMP
Statistics website: Ryba, Peter, PharmD - PMP Director 5500 San Antonio Drive NE, Suite C Albuquerque NM 87109 Office: (505) 222-9818 Fax: (505) 222-9845 Email: peter.ryba@state.nm.us New Mexico PDMP name:
More informationColorado. Contact Information
Colorado PDMP name: Prescription Drug Monitoring Program PDMP region: Agency responsible: Colorado State Board of Pharmacy Agency type: Pharmacy Board PDMP email: pdmpinqr@state.co.us PDMP website: https://www.colorado.gov/pacific/dora/pdmp
More informationMassachusetts. Contact Information. State Registrant Totals and Population. PDMP name: MA Prescription Monitoring Program
Massachusetts PDMP name: MA Prescription Monitoring Program PDMP region: Agency responsible: Department of Public Health Agency type: Department of Health PDMP email: mapmp.dph@massmail.state.ma.us PDMP
More informationNevada. Contact Information. State Registrant Totals and Population
Statistics website: Long, Yenh - Program Administrator 431 W Plumb Ln Reno NV 89509 Office: (775) 687-5694 Fax: (775) 687-5161 Email: ylong@pharmacy.nv.gov Nevada PDMP name: Prescription Controlled Substance
More informationOverview of the Changes to the Meaningful Use Program Called for in the Proposed Inpatient Prospective Payment System Rule April 27, 2018
Overview of the Changes to the Meaningful Use Program Called for in the Proposed Inpatient Prospective Payment System Rule April 27, 2018 NOTE: These policies have only been proposed. No policies are final
More informationSteps Taken to Combat the Opiate Epidemic Through Legal And Technological Channels. Nick Snyder, Esq.
Steps Taken to Combat the Opiate Epidemic Through Legal And Technological Channels Nick Snyder, Esq. How Can We Impact Inappropriate Over-Prescribing of Opioids in Maine? What have other States or Organizations
More informationPuerto Rico. Contact Information. State Registrant Totals and Population. PDMP name: PR PDMP
Statistics website: Rodriguez, Cieni - Program Manager Carr. No. 2 Km 8.2, Bo. Juan Sanchez Bayamon, PR 00960 Office: (787) 763-7575 Fax: (787) 763-3152 Email: cieni.rodriguez@assmca.pr.gov Puerto Rico
More informationMississippi. Contact Information. State Registrant Totals and Population
Statistics website: Mueller, Stephanie - PMP Director 6360 I-55 North, Suite 400 Jackson, MS 39211 Office: (601) 899-0138 Fax: (601) 899-8904 Email: smueller@mbp.ms.gov Mississippi PDMP name: MS PMP Agency
More informationOverview. Appriss Health Substance Use and Opioid Trends NarxCare Overview Live Demo
Solution Overview Overview Appriss Health Substance Use and Opioid Trends NarxCare Overview Live Demo 2 Appriss Health Software provider for 42 of 52 PDMPs in U.S. Software provider for PMP Interconnect
More informationTechnical Assistance Guide. Enhancing PDMPs: A Comparison of Changes 2010 to 2016
Technical Assistance Guide Enhancing PDMPs: A Comparison of Changes 2010 to 2016 December 2016 This project was supported by Grant No. 2014-PM-BX-K001 awarded by the Bureau of Justice Assistance. The Bureau
More informationTechnical Assistance Guide. Prescriber Report Cards
Technical Assistance Guide Prescriber Report Cards Revised February 17, 2017 This project was supported by Grant No. 2014-PM-BX-K001 awarded by the Bureau of Justice Assistance. The Bureau of Justice Assistance
More informationStates that Allow Prescribers and/or Dispensers to Appoint a Delegate to Access the PMP
States that Allow Prescribers and/or Dispensers to Appoint a Delegate to Access the PMP Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office
More informationTypes of Authorized Recipients Probation/Parole Officers or the Department of Corrections
Types of Authorized Recipients Probation/Parole Officers or the Department of Corrections Research current through May 2016. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office
More informationHealth Information Exchange 101. Your Introduction to HIE and It s Relevance to Senior Living
Health Information Exchange 101 Your Introduction to HIE and It s Relevance to Senior Living Objectives for Today Provide an introduction to Health Information Exchange Define a Health Information Exchange
More informationSTATE OF TEXAS TEXAS STATE BOARD OF PHARMACY
STATE OF TEXAS TEXAS STATE BOARD OF PHARMACY REQUEST FOR INFORMATION NO. 515-15-0002 PRESCRIPTION DRUG MONITORING PROGRAM Reference: CLASS: 920 ITEM: 05 Posting Date: 12/08/2014 RESPONSE DEADLINE: 01/05/2015
More informationPrescription Monitoring Program State Profiles - California
Prescription Monitoring Program State Profiles - California Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control
More informationAutomation and Information Technology
4 Automation and Information Technology Positions Automation and Information Technology Ensuring Patient Safety and Data Integrity During Cyber-attacks (1701) To advocate that healthcare organizations
More informationPrescription Drug Monitoring Program (PDMP)
Prescription Drug Monitoring Program (PDMP) New Jersey Information contained in this presentation is accurate as of September 2017 Meet the Speaker Sindy Paul, MD, MPH, FACPM Medical Director - NJ Board
More informationGeorgia DPH. Prescription Title Drug Heading Monitoring Program Program. Sheila Pierce April 2018
Georgia DPH Prescription Title Drug Heading Monitoring Program Program Sheila Pierce April 2018 What is the PDMP? Legislative Mandates Registration Requirements How to use the PDMP Next Steps for Prescribers
More informationDistrict of Columbia Prescription Drug Monitoring Program
District of Columbia Prescription Drug Monitoring Program What Our Users Need to Know Health Regulation and Licensing Administration Pharmaceutical Control Division February 28, 2017 1 Mission Statement
More informationPrescription Monitoring Programs - Legislative Trends and Model Law Revision
Prescription Drug Monitoring Programs Training and Technical Assistance Center Webinar Series National Alliance for Model State Drug Laws: Legislative Round-Up July 22, 2015 Prescription Monitoring Programs
More informationTennessee. Tennessee Department of Health, Tennessee Board of Pharmacy Pharmacy Board
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Tennessee Tennessee Department of Health, Tennessee Board of Pharmacy Pharmacy Board http://tn.gov/health/topic/csmd-board csmd.admin@tn.gov
More informationK-TRACS: Review of Program Data and a Qualitative Assessment Study
K-TRACS: Review of Program Data and a Qualitative Assessment Study Amy Curry, MD Clinical Assistant Professor University of Kansas School of Medicine - Wichita Department of Family and Community Medicine
More informationA Guide for Kentucky APRNs:
A Guide for Kentucky APRNs: Prescribing Controlled Substances Compiled by the Kentucky Coalition of Nurse Practitioners and Nurse-Midwives Elizabeth Partin, DNP, APRN Legislative Committee Chair Kentucky
More informationAnnual Report to the Prescription Drug Monitoring Program Advisory Commission
2015 Annual Report to the Prescription Drug Monitoring Program Advisory Commission PUBLIC HEALTH DIVISION Oregon Violent Death Reporting System Contents»» Acknowledgments... 1»» Executive summary... 2
More informationHow to Get the Most Out of Prescription Drug Monitoring Programs
How to Get the Most Out of Prescription Drug Monitoring Programs Target Audience: Pharmacists and Pharmacy Technicians ACPE#: 0202-0000-18-019-L03-P/T Activity Type: Knowledge-based Disclosures I own 40
More informationPRESCRIBING IN NEVADA
PRESCRIBING IN NEVADA An Inside Look at Changes to Nevada Laws Surrounding Prescribing Controlled Substances for the Treatment of Pain These changes to Nevada law do not impact the authority of practitioners
More informationPRESCRIPTION MONITORING PROGRAM STATE PROFILES TENNESSEE
PRESCRIPTION MONITORING PROGRAM STATE PROFILES TENNESSEE Research current through July 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
More informationStates that Allow Prescribers and/or Dispensers to Appoint a Delegate to Access the PMP
States that Allow Prescribers and/or Dispensers to Appoint a Delegate to Access the PMP Research current through May 2016. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of
More informationPrescription Drug Monitoring Programs: Promising Practices to Maximize Their Effectiveness
Prescription Drug Monitoring Programs: Promising Practices to Maximize Their Effectiveness Peter Kreiner, Ph.D. Prescription Monitoring Program Center of Excellence at Brandeis University NGA Meeting September
More informationHow can oncology practices deliver better care? It starts with staying connected.
How can oncology practices deliver better care? It starts with staying connected. A system rooted in oncology Compared to other EHRs that I ve used, iknowmed is the best EHR for medical oncology. Physician
More informationHB 1 Regulations Board of Medical Licensure
HB 1 Regulations Board of Medical Licensure C. Lloyd Vest II, J.D. General Counsel Kentucky Board of Medical Licensure Faculty Disclosure I have not had any relevant financial relationships during the
More informationPromoting Interoperability Measures
Promoting Interoperability Measures Previously known as Advancing Care Information for 2017 and Meaningful Use from 2011-2016 Participants: In 2018, promoting interoperability measure reporting (PI) is
More informationSENATE, No STATE OF NEW JERSEY. 216th LEGISLATURE INTRODUCED APRIL 28, 2014
SENATE, No. STATE OF NEW JERSEY th LEGISLATURE INTRODUCED APRIL, 0 Sponsored by: Senator LORETTA WEINBERG District (Bergen) Senator JOSEPH F. VITALE District (Middlesex) Senator JAMES W. HOLZAPFEL District
More information-Health Update. Encounter Notification System (ENS) Celebrates Five Years! Welcome
www.crisphealth.org e -Health Update ISSUE 8 Summer 2017 Welcome The e-health Update is a resource that shares current CRISP initiatives as well as pertinent health care related information for our region.
More informationNATIONAL ASSOCIATION FOR STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT (2016) COMMENT
1 NATIONAL ASSOCIATION FOR STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT (2016) SECTION 1. SHORT TITLE. This Act shall be known and may be cited as the
More informationPrescription Monitoring Program State Profiles - Illinois
Prescription Monitoring Program State Profiles - Illinois Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
More informationCIO Legislative Brief
CIO Legislative Brief Comparison of Health IT Provisions in the Committee Print of the 21 st Century Cures Act (dated November 25, 2016), H.R. 6 (21 st Century Cures Act) and S. 2511 (Improving Health
More informationMeaningful Use Stage 2
Meaningful Use Stage 2 Presented by: Deb Anderson, HTS Consultant HTS, a division of Mountain Pacific Quality Health Foundation 1 HTS Who We Are Stage 2 MU Overview Learning Objectives 2014 CEHRT Certification
More informationMassachusetts Prescription Monitoring Program
Massachusetts Prescription Monitoring Program PDMP Training and Technical Assistance Center at Brandeis University in partnership with the Bureau of Justice Assistance August 8, 2012 Massachusetts Department
More informationPharmacy Pain Management Protocol Pharmacy Policy and Protocol
Line of Business: Medicare and Medi-Cal Effective Date: November 18, 2015 Renewal Date: August 16, 2017 Pharmacy Pain Management Protocol Pharmacy Policy and Protocol This protocol has been developed through
More informationPolicies Approved by the 2017 ASHP House of Delegates
House of Delegates Policies Approved by the 2017 ASHP House of Delegates 1701 Ensuring Patient Safety and Data Integrity During Cyber-attacks Source: Council on Pharmacy Management To advocate that healthcare
More informationBEST PRACTICES: DOCUMENTATION OF CLINICAL RATIONALE FOR CHRONIC OPIOID THERAPY THE LEGAL PERSPECTIVE PART I. The presentation was created by
BEST PRACTICES: DOCUMENTATION OF CLINICAL RATIONALE FOR CHRONIC OPIOID THERAPY THE LEGAL PERSPECTIVE PART I Jennifer Bolen, JD Former Federal Prosecutor Founder, the Legal Side of Pain Presented August
More informationQuality Management Building Blocks
Quality Management Building Blocks Quality Management A way of doing business that ensures continuous improvement of products and services to achieve better performance. (General Definition) Quality Management
More informationOptum Anesthesia. Completely integrated anesthesia information management system
Optum Anesthesia Completely integrated anesthesia information management system 2 Completely integrated anesthesia information management system Optum Anesthesia Information Management System (AIMS) helps
More informationDelegator Dashboard User Guide
Delegator Dashboard User Guide ULP Delegator Dashboard Technical Guide This guide is intended for a Prescriber or Pharmacist who is utilizing Delegates to facilitate PDMP data access. A separate guide
More informationMedCheck Frequently Asked Questions (FAQ) (Physician, AHP) GETTING STARTED
GETTING STARTED What is MedCheck? MedCheck is an application used to electronically enter and approve home medication orders. MedCheck will act as the place for maintaining the home med lists for your
More informationMeaningful Use Overview for Program Year 2017 Massachusetts Medicaid EHR Incentive Program
Meaningful Use Overview for Program Year 2017 Massachusetts Medicaid EHR Incentive Program October 23 & 24, 2017 Presenters: Elisabeth Renczkowski, Al Wroblewski, and Thomas Bennett Agenda 2017 Meaningful
More informationCore Item: Hospital. Cover Page. Admissions and Readmissions. Executive Summary
Cover Page Core Item: Hospital Admissions and Readmissions Name of Applicant Organization: Horizon Family Medical Group Organization s Address: 4 Coates Drive, Goshen NY 10924 Submitter s Name: Rinku Singh
More information10/4/12. Controlled Substances Dispensing Issues and Solutions. Objectives. Financial Disclosure
Controlled Substances Dispensing Issues and Solutions Ronald W. Buzzeo, R.Ph. Chief Compliance Officer November 7, 2012 CE Code: Financial Disclosure I have no actual or potentially relevant financial
More informationRole of e-prescribing in Preventing Opioid Abuse
Role of e-prescribing in Preventing Opioid Abuse John Klimek R.Ph. Senior Vice President Standards and Industry IT NCPDP March 16, 2017 Agenda Opioid Epidemic PDMP Benefits and Challenges Comprehensive
More informationMedication Assisted Treatment for Opioid Use Disorders Reporting Requirements
This document is scheduled to be published in the Federal Register on 09/27/2016 and available online at https://federalregister.gov/d/2016-23277, and on FDsys.gov DEPARTMENT OF HEALTH AND HUMAN SERVICES
More information*State Board of Pharmacy Updates
UPDATES August 22, 2017 Alexandra Blasi, JD, MBA Executive Secretary I speak for myself and do not intend to represent the thoughts or opinions of any others. Any opinions expressed in this presentation
More informationOptimizing Medication Distribution using Automated Dispensing Cabinets
Optimizing Medication Distribution using Automated Dispensing Cabinets Conflict of Interest Declaration I have no actual or potential conflicts of interest in relation to this presentation or activity
More informationChristopher W. Shanahan, MD, MPH, FACP
Safe and Competent Opioid Prescribing: Optimizing Office Systems Christopher W. Shanahan, MD, MPH, FACP Assistant Professor of Medicine Boston University School of Medicine Boston Medical Center Certified:
More information247 CMR: BOARD OF REGISTRATION IN PHARMACY
247 CMR 9.00: CODE OF PROFESSIONAL CONDUCT; PROFESSIONAL STANDARDS FOR REGISTERED PHARMACISTS, PHARMACIES AND PHARMACY DEPART- MENTS Section 9.01: Code of Professional Conduct for Registered Pharmacists,
More informationPrescriber Use of the PDMP: A Statewide Survey and Multistate Focus Groups
Prescriber Use of the PDMP: A Statewide Survey and Multistate Focus Groups Richard Deyo, MD, MPH Depts. of Family Medicine & Internal Medicine, Oregon Health & Science University Jessica Irvine, MS Acumentra
More informationPrescription Monitoring Program State Profiles - Kentucky
Prescription Monitoring Program State Profiles - Kentucky Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
More informationPrescription Drug Monitoring Program (PDMP) LOUISIANA. Information contained in this presentation is accurate as of September 2017
Prescription Drug Monitoring Program (PDMP) LOUISIANA Information contained in this presentation is accurate as of September 2017 Meet the Speaker Julie W. Breithaupt PharmD, MBA President Louisiana Pharmacists
More informationInterim Commissioner Lauren A. Smith and Members of the Public Health Council
DEVAL L. PATRICK GOVERNOR TIMOTHY P. MURRAY LIEUTENANT GOVERNOR JOHN W. POLANOWICZ SECRETARY LAUREN A. SMITH, MD, MPH INTERIM COMMISSIONER The Commonwealth of Massachusetts Executive Office of Health and
More informationPrescription Monitoring Program State Profiles - Pennsylvania
Prescription Monitoring Program State Profiles - Pennsylvania Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control
More informationOklahoma. Contact Information. Office: Fax: Statistics
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Vogt, Don - PMP Program Manager 419 NE 38th Terrace Oklahoma City OK 73105 Office: (405) 530-3140 Fax: (405) 524-7619 Email: dvogt@obn.state.ok.us
More informationBold blue=new language Red strikethrough=deleted language Regular text=existing language Bold Green = new changes following public hearing
Bold blue=new language Red strikethrough=deleted language Regular text=existing language Bold Green = new changes following public hearing 700.001: Definitions Delegate means an authorized support staff
More informationCHAPTER 15 F425 - PHARMACY SERVICES THE MEDICATION AUDIT TRAIL (ORDERING, RECEIVING AND DISPOSITION OF MEDICATION) 15.1
CHAPTER 15 F425 - PHARMACY SERVICES THE MEDICATION AUDIT TRAIL (ORDERING, RECEIVING AND DISPOSITION OF MEDICATION) 15.1 THE PRESCRIPTION AUDIT TRAIL I. Regulatory Overview STATE 59A-4.112 Florida Nursing
More informationSouth Carolina Reporting & Identification Prescription Tracking System (SCRIPTS)
South Carolina Reporting & Identification Prescription Tracking System (SCRIPTS) Note! Contents are subject to change and are not a guarantee of payment. Webinar Reminders Webinar Reminders Agenda Welcome
More information2015 Complete Overview of the NCQA Standards Session Code: TU13 Time: 2:30 p.m. 4:00 p.m. Total CE Credits: 1.5 Presenter: Frank Stelling, MEd, MPH
2015 Complete Overview of the NCQA Standards Session Code: TU13 Time: 2:30 p.m. 4:00 p.m. Total CE Credits: 1.5 Presenter: Frank Stelling, MEd, MPH Introduction to NCQA Credentialing Standards NAMSS Educational
More informationComparison of Health IT Provisions in H.R. 6 (21 st Century Cures Act) and S (Improving Health Information Technology Act)
Comparison of Health IT Provisions in H.R. 6 (21 st Century Cures Act) and S. 2511 (Improving Health Information Technology Act) Policy Proposal Health Software Regulation Senate Innovations Initiative
More informationeprescribing Information to Improve Medication Adherence
eprescribing Information to Improve Medication Adherence April 2017 (revised) About Point-of-Care Partners Executive Summary Point-of-Care Partners (POCP) is a leading management consulting firm assisting
More informationReport of the Task Force on Prescription Monitoring Program Standards
Report of the Task Force on Prescription Monitoring Program Standards Members Present: Gay Dodson (TX), chairperson; John Dorvee (ME); Danna Droz (OH); Allen F. Dulwick (OR); William Fitzpatrick (MO);
More informationCHAPTER 29 PHARMACY TECHNICIANS
CHAPTER 29 PHARMACY TECHNICIANS 29.1 HOSPITAL PHARMACY TECHNICIANS 1. Proper Identification as Pharmacy Technician 2. Policy and procedures regulating duties of technician and scope of responsibility 3.
More information1. What are the requirements for Stage 1 of the HITECH Act for CPOE to qualify for incentive payments?
CPPM Chapter 8 Review Questions 1. What are the requirements for Stage 1 of the HITECH Act for CPOE to qualify for incentive payments? a. At least 30% of the medications in the practice must be ordered
More information1 Title Improving Wellness and Care Management with an Electronic Health Record System
HIMSS Stories of Success! Graybill Medical Group 1 Title Improving Wellness and Care Management with an Electronic Health Record System 2 Background Knowledge It is widely understood that providers wellness
More informationE-Prescribing: What Is It? Why Should I Do It? What's in the Future?
American College of Physicians Internal Medicine 2008 Washington, DC May 15-17, 2008 E-Prescribing: What Is It? Why Should I Do It? What's in the Future? Daniel Z. Sands, MD, MPH, FACP Posted Date:May
More informationNCPDP s Recommendations for an Integrated, Interoperable Solution to Ensure Patient Safe Use of Controlled Substances
National Council for Prescription Drug Programs White Paper NCPDP s Recommendations for an Integrated, Interoperable Solution to Ensure Patient Safe Use of This white paper details a plan to nationally
More informationBreaking HIE Barriers
Breaking HIE Barriers Session #20, February 20, 2017 Robert M. Cothren, PhD, Executive Director California Association of Health Information Exchanges 1 Speaker Introduction Robert M. Cothren, PhD Executive
More informationOREGON HEALTH AUTHORITY, DIVISION OF MEDICAL ASSISTANCE PROGRAMS
OREGON HEALTH AUTHORITY, DIVISION OF MEDICAL ASSISTANCE PROGRAMS DIVISION 121 PHARMACEUTICAL SERVICES Non-Medicaid Rules Prescription Drug Monitoring Program 410-121-4000 Purpose The purpose of the Prescription
More informationGeneral Administration GA STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility
General Administration GA 102.01 STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility Approval: Nancy Paris, MS, FACHE President and CEO (17 July 2014) (Signature and
More informationUNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2017 October 1 st, 2016
UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2017 October 1 st, 2016 Department Name: Department of Pharmacy Department Director: Steve Rough, MS,
More informationLong Term Care Pharmacy
Long Term Care Pharmacy Medication Reconciliation in The Electronic Age Courtney Doherty Oland R.Ph, MBA President The LTC setting is currently under enormous transformation silver tsunami - greater demand/
More information1. When will physicians who are not "meaningful" EHR users start to see a reduction in payments?
CPPM Chapter 7 Review Questions 1. When will physicians who are not "meaningful" EHR users start to see a reduction in payments? a. January 1, 2013 b. January 1, 2015 c. January 1, 2016 d. January 1, 2017
More informationPrescription Monitoring Program State Profiles - Michigan
Prescription Monitoring Program State Profiles - Michigan Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
More informationFast & Furious: erx/epcs Implementation and Optimization
Fast & Furious: erx/epcs Implementation and Optimization Session #273, March 6, 2018 Connie L. Saltsman, Pharm.D., MBA, CPHIMS; AVP, Clinical Pharmacy Informatics Risa C. Rahm, Pharm.D., CPHIMS; Director,
More informationThe Challenges of Interstate Data Sharing
The Challenges of Interstate Data Sharing 2016 Harold Rogers Prescription Drug Monitoring Program National Meeting August 17 19, 2016 Background The Challenges of Interstate Data Sharing Prescription Monitoring
More informationCMS Incentive Programs: Timeline And Reporting Requirements. Webcast Association of Northern California Oncologists May 21, 2013
CMS Incentive Programs: Timeline And Reporting Requirements Webcast Association of Northern California Oncologists May 21, 2013 Objective This webcast will address CMS s Incentive Program reporting requirements
More informationLSU First & WebTPA: Working Together
LSU First & WebTPA: Working Together 2016 LSU First Health Plan Changes 2016 LSU First Health Plan Changes New ID Card Specialty drug copay $150 90 day timely filing period (medical and pharmacy) Home
More informationOffice of Inspector General
Office of Inspector General Mary Reinle Begley Inspector General Division of Health Care Division of Regulated Child Care Division of Audits & Investigations Division of Health Care Health Care facility
More information2017 ASAP MIDYEAR CONFERENCE THE FUTURE OF PRESCRIPTION DRUG MONITORING PROGRAMS (PMPS): HIGHLIGHTS OF 2017 STATE BILLS JUNE 22, 2017 SHERRY L.
2017 ASAP MIDYEAR CONFERENCE THE FUTURE OF PRESCRIPTION DRUG MONITORING PROGRAMS (PMPS): HIGHLIGHTS OF 2017 STATE BILLS JUNE 22, 2017 SHERRY L. GREEN Disclosures Sherry Green is an employee of Na2onal
More informationMaine Chronic Pain Collaborative 2 (ME CPC2) Chronic Pain Management Change Package for Primary Care Practices
Maine Chronic Pain Collaborative 2 (ME CPC2) Chronic Pain Management Change Package for Primary Care Practices These 10 change components are intended to support enhanced safety and improved patient care
More informationCalibrating your tablet allows you to ensure accuracy as you handwrite on the screen and/or select items on the screen. Prime Clinical Systems, Inc 1
Calibrating your tablet allows you to ensure accuracy as you handwrite on the screen and/or select items on the screen. 1 Every user has the capability to set various defaults for themselves. 2 You can
More informationBuilding a Better Home: Transformation to a Patient Centered Health Home. Anna M. Gard, FNP-BC Association of Clinicians for the Underserved
Building a Better Home: Transformation to a Patient Centered Health Home Anna M. Gard, FNP-BC Association of Clinicians for the Underserved A Patient Centered Health Home is not a place but an approach
More information